// App-Quantinova.ai

: Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results

Researchers

Presenter

  • Alice Turner

Principal Investigators

  • Maria Torres

  • José Luis López-Campos

  • Catarina Guimaraes

  • Joana Chorostowska-Wynimko

  • Robert Bals

  • Ilaria Ferrarotti

  • Gerard Mcelvaney

  • Karen O’Hara

  • Jan Stolk

  • Robert Stockley

  • Marion Wilkens

  • Christian Clarenbach

  • Timm Greulich

  • Marc Miravitlles

Medical Centers

  • Patientenorganisation Alpha1 Deutschland e.V, Berlin, Germany

  • Leiden University Medical Centre, Leiden, Netherlands

  • University Hospital of Zurich, Zurich, Switzerland

  • Institute for Tuberculosis and Lung Disease, Warszawa, Poland

  • University Medical Center of Giessen and Marburg, Marburg, Germany

  • San Matteo Hospital Foundation, Pavia, Italy

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Alpha-1 UK Support Group, Coventry, United Kingdom

  • Hospital da Senhora da Oliveira - Guimaraes, Guimaraes, Portugal

  • Hospital Alvaro Cunqueiro, Vigo, Spain

  • Beaumont Hospital, RCSI, Dublin, Ireland

  • Saarland University Hospitals, Homburg/Saar, Germany

  • Hospital Virgen del Rocio, Sevilla, Spain

Locations

  • Portugal

  • United Kingdom

  • Switzerland

  • Germany

  • Poland

  • Italy

  • Netherlands

  • Spain

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Alpha-1 antitrypsin (A1AT) deficiency

  • Coronavirus disease

Biomarkers

  • Alpha-1 antitrypsin

  • Catalase

Drug/Treatment

  • Alpha 1-Antitrypsin

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved